Lukatch Heath's Form 4 filing
Vaxcyte, Inc. (PCVX) · filed Dec 14, 2022
- Accession no.
- 0001209191-22-061256
- Filed
- Dec 14, 2022
- Trade date
- Dec 12, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 3 non-derivative transactions and 1 derivative transaction. Open-market sales total $14.7K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Lukatch HeathCIK 0001596385 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 12, 2022 | Common Stock | MOption exerciseAcquired | +335 | $16.00 | +$5,360 | 3,460 | Direct | |
| Dec 12, 2022 | Common Stock | SSaleDisposed | −16 | $42.37 | −$677.92 | 3,444 | Direct | |
| Dec 12, 2022 | Common Stock | SSaleDisposed | −319 | $44.01 | −$14,039.19 | 3,125 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 12, 2022 | Common Stock | MOption exerciseDisposed | −335 | $0.00 | $0 | 28,315 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.